KEMBLE GEORGE sold 85.0% of their position (350.99K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market sale worth $3.59M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/17/2026ACC: 0001193125-26-354018
-350.99K
Net shares
Net seller
$3.59M
Total sold
1
Open market trades
0B · 1S
5
Total transactions
350.99K acquired · 701.97K disposed
Non-Derivative Transactions3
Series A Common Stock
Direct
Shares
+326.62K
Price / share
$6.36
Trade value
$2.08M
% of position
525.4%
8/14/2026
62.16K→388.78K
Series A Common Stock
Direct
Shares
+24.37K
Price / share
$6.36
Trade value
$154.99K
% of position
6.3%
8/14/2026
388.78K→413.15K
Series A Common Stock
Direct
Shares
−350.99K
Price / share
$10.23
Trade value
$3.59M
% of position
85.0%
8/14/2026
413.15K→62.16K
Total
Net shares
+0.00
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 8/14/2026 | M · Option Exercise | +326.62K | $6.36 | $2.08M | 525.4% | 62.16K | 388.78K |
| Series A Common Stock Direct | 8/14/2026 | M · Option Exercise | +24.37K | $6.36 | $154.99K | 6.3% | 388.78K | 413.15K |
| Series A Common Stock Direct | 8/14/2026 | S · Sale | −350.99K | $10.23 | $3.59M | 85.0% | 413.15K | 62.16K |
| Total | +0.00 | -$1.36M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Series A Common Stock
326.62K shares
Shares
−326.62K
Strike price
6.36
Held after
31.45K
Exercisable
—
8/14/2026
Stock Option (Right to Buy)
Direct
Converts to
Series A Common Stock
24.37K shares
Shares
−24.37K
Strike price
6.36
Held after
11.61K
Exercisable
—
8/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Series A Common Stock326.62K shares | 8/14/2026 | M · Option Exercise | −326.62K | 6.36 | — | 31.45K |
| Stock Option (Right to Buy) Direct | Series A Common Stock24.37K shares | 8/14/2026 | M · Option Exercise | −24.37K | 6.36 | — | 11.61K |